Acadia Pharmaceuticals ACAD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $375.65M+64.1% | $391M+72.7% | $261.17M+103% | $222.16M+627% | $228.88M+13,485% | ||
| $913K+0.7% | $871K-5.3% | $895K-7.3% | $894K-18.7% | $907K-28.9% | ||
| $55.45M-12.9% | $52.14M-22.2% | $49.35M-33.9% | $62.33M-7.0% | $63.68M-4.2% | ||
| —— | —— | $198.95M-1.9% | $187.91M+133% | $148.96M+134% | ||
| $9.9M— | $4.69M— | $1.14M— | $820K— | —— | ||
| -$112.23M— | -$302.56M— | —— | —— | —— | ||
| $52.28M+584% | $49.88M+629% | $29.19M+183% | $20.03M-12.1% | $7.64M-69.1% | ||
| —— | —— | —— | —— | $15.95M+119% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Acadia Pharmaceuticals generate?
- Acadia Pharmaceuticals (ACAD) generated $192.5M in operating cash flow over the trailing twelve months.
- What is Acadia Pharmaceuticals's free cash flow?
- After $9.9M of capital expenditures, Acadia Pharmaceuticals's free cash flow was $186.7M over the trailing twelve months, up 13.4% year over year.
- Where does Acadia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
